West Pharmaceutical Services revenue
West Pharmaceutical Services's revenue was $3.07bn in fiscal 2025, up 6.3% on the year before. Since fiscal 2009 ($1.06bn) it has grown at a compound 6.9% a year. Over the last twelve months it was $3.40bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1,056 | 1,105 | 1,192 | 1,266 | 1,368 | 1,421 | 1,400 | 1,509 | 1,599 | 1,717 | 1,840 | 2,147 | 2,832 | 2,887 | 2,950 | 2,893 | 3,074 | 3,397 |
| Growth on the year before | — | +4.6% | +7.9% | +6.2% | +8.1% | +3.9% | −1.5% | +7.8% | +6.0% | +7.4% | +7.1% | +16.7% | +31.9% | +2.0% | +2.2% | −1.9% | +6.3% | — |
| Gross profit | 304 | 318 | 339 | 388 | 435 | 448 | 456 | 501 | 513 | 545 | 606 | 768 | 1,176 | 1,136 | 1,129 | 999 | 1,104 | 1,277 |
| Gross margin | 28.8% | 28.8% | 28.5% | 30.6% | 31.8% | 31.5% | 32.6% | 33.2% | 32.1% | 31.8% | 32.9% | 35.8% | 41.5% | 39.4% | 38.3% | 34.5% | 35.9% | 37.6% |
Where the revenue comes from
| Line of business | Revenue | Share | YoY |
|---|---|---|---|
| Proprietary Products | $2.5B | 81.1% | ▲ 6.8% |
| Contract Manufactured Products | $582M | 18.9% | ▲ 4.2% |
| Region | Revenue | Share | YoY |
|---|---|---|---|
| United States | $1.3B | 43.3% | ▲ 8.0% |
| Other Europe Countries | $451M | 14.7% | ▲ 17.0% |
| Germany | $380M | 12.4% | ▲ 2.1% |
| Other Countries | $353M | 11.5% | ▲ 4.2% |
| Ireland | $333M | 10.8% | ▲ 3.1% |
| France | $227M | 7.4% | ▼ 6.4% |
From West Pharmaceutical Services's 10-K filed February 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| West Pharmaceutical Services | $3.40bn | 12.6% | 5.1% |
| Dentsply Sirona Inc. | $3.64bn | -0.8% | -2.5% |
| Envista Holdings Corp | $2.86bn | 11.9% | 3.4% |
| Align Technology | $4.14bn | 4.4% | 3.5% |
| The Cooper Companies | $4.24bn | 4.7% | 6.4% |
| ICU Medical Inc | $2.16bn | -9.0% | -2.0% |
Compare with peers
- Dentsply Sirona Inc. revenue
- Envista Holdings Corp revenue
- Align Technology revenue
- The Cooper Companies revenue
- ICU Medical Inc revenue
Head to head: WST vs XRAYNVST vs WSTALGN vs WSTCOO vs WST
More: Health Care Supplies stocks compared, Health Care sector, rankings of US companies